1. Ackman says Allergan holders back takeover at $180/shr: CNBC

    Ackman says Allergan holders back takeover at $180/shr: CNBC

    Valeant and Ackman, who owns almost 10 percent of Allergan through Pershing Square Capital Management, are in the midst of a hostile takeover battle for Allergan that began with a joint bid on April 22. Allergan rejected that first offer and Valeant responded by raising its offer on May 28 to about $163 per share. Ackman, speaking on CNBC in his first public appearance regarding the takeover ...

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content
  2. Topics Mentioned